Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

IFN-gamma-release assays to diagnose TB infection in the immunocompromised individual.

Domínguez, Jose; Latorre, Irene; Altet, Neus; Mateo, Lourdes; De Souza-Galvão, Malú; Ruiz-Manzano, Juan; Ausina, Vicente.
Expert Rev Respir Med; 3(3): 309-27, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20477323
The tuberculin skin test (TST) is used for diagnosing latent TB infection (LTBI). The main limitation of TST is its low sensitivity in populations with the highest risk of progression to active TB: immunosuppressed patients and young children. New IFN-gamma-based tests appear as an alternative to the TST. IFN-gamma-based tests seem more specific than the TST, being closely associated with LTBI factors, and not being affected by bacillus Calmette-Guérin vaccination. Indeterminate results are mainly related to immunosuppression. Looking at the available data, it seems prudent to recommend the utilization of IFN-gamma-based tests after a negative TST result, in order to increase the sensitivity of detecting LTBI cases in severely immunosuppressed patients. In summary, IFN-gamma-based tests appear to be a valuable tool, in combination with the TST, for diagnosing TB infection in immunosuppressed patients.
Selo DaSilva